Daily pre exposure prophylaxis, commonly known as PrEP, is a medication approach used to reduce the risk of acquiring HIV. It is intended for people who do not have HIV but may have an increased likelihood of exposure. When taken as prescribed, daily oral PrEP can substantially reduce the risk of HIV transmission through sexual contact and injection drug use. Understanding how PrEP works, who may benefit from it, and why regular medical appointments are necessary helps individuals make informed decisions about HIV prevention. HIV testing, medication adherence, and appropriate follow up remain important parts of an effective prevention plan.
Daily pre exposure prophylaxis (PrEP) is an important HIV prevention method for people who do not have HIV. It involves taking specific prescription medications to lower the risk of acquiring the virus. Daily oral PrEP works by maintaining medication levels in the body that help prevent HIV from establishing an infection following exposure. Its effectiveness depends on taking the medication consistently and following medical advice. PrEP is one component of HIV prevention and can be considered alongside other preventive measures according to individual circumstances.
Daily PrEP medication works by preventing HIV from establishing an infection in the body. When taken consistently as prescribed, it provides a high level of protection against acquiring HIV through sexual contact. It can also reduce the risk associated with sharing injection equipment. However, PrEP does not prevent other sexually transmitted infections or pregnancy.
Before starting PrEP, individuals need an HIV test to confirm that they do not have HIV. Medical professionals assess eligibility, review relevant health information, and determine which medication is appropriate. Regular follow up is necessary to monitor HIV status, medication use, and potential side effects.
Key aspects of daily PrEP include:
Consistent medication use: Taking PrEP according to the prescribed schedule helps maintain protective medication levels.
HIV testing: Testing before starting treatment and at recommended intervals helps identify HIV infection.
Medical assessment: Healthcare professionals evaluate kidney function when required for the prescribed oral medication and review other relevant health considerations.
Additional prevention measures: Condoms and sterile injection equipment can provide additional protection against HIV and other infections.
Ongoing monitoring: Follow up appointments help assess medication tolerance, adherence, and continuing prevention needs.
Daily PrEP may be appropriate for HIV negative individuals who anticipate possible exposure to HIV. This can include people whose sexual partners have HIV, individuals who do not consistently use condoms, and people who share injection equipment. Eligibility depends on personal circumstances and clinical assessment.
PrEP is available in different medication formulations, and not every option is suitable for everyone. Daily oral PrEP generally involves taking a prescribed tablet each day. Individuals should discuss the appropriate medication and schedule with a healthcare professional rather than starting or changing medication independently.
Important considerations for using daily PrEP include:
Confirming HIV negative status: An appropriate HIV test is required before beginning PrEP, with repeat testing during follow up.
Following prescriptions: Medication should be taken as directed, and missed doses should be discussed with a healthcare professional.
Reviewing side effects: Some people experience nausea, headache, or other side effects, particularly when first starting medication.
Attending follow up visits: Regular appointments support HIV testing, monitoring, and prescription management.
Understanding limitations: PrEP greatly reduces HIV risk when used correctly but does not eliminate every possibility of infection.
Daily PrEP is a preventive medication strategy rather than a treatment for established HIV infection. People who may have been exposed to HIV within the previous 72 hours should seek urgent medical advice about post exposure prophylaxis (PEP), which is a different prevention approach. Understanding the differences between these options, maintaining regular medical care, and using medication consistently can support informed HIV prevention decisions.